TNF and rheumatoid arthritis: Similar results were obtained when analyzing each treatment group longitudinally: SpA patients receiving anti-TNF drugs (P = 1.00), RA patients receiving anti-TNF drugs (P = 0.94) and RA patients receiving MTX (P = 0.74).